by admin | May 1, 2023 | News & Opinions
By Catherine Eckford – European Pharmaceutical Review The first allogeneic stem cell transplant therapy to be approved based on Phase III study results has been granted by the US Food and Drug Administration (FDA). Allogeneic hematopoietic stem cell...
by admin | Apr 27, 2023 | News & Opinions
By Natalie Lisbona – BBC News Dr Talia Cohen Solal sits down at a microscope to look closely at human brain cells grown in a petri dish. “The brain is very subtle, complex and beautiful,” she says. A neuroscientist, Dr Cohen Solal is the co-founder...
by admin | Apr 26, 2023 | News & Opinions
by Jasmine Hagan – RegMedNet The UK is set to be the second country to trial a pioneering stem cell robot to improve the manufacture of safe and cost-effective cell-based therapeutics. Manufacturing challenges have limited the availability of stem cell-based...
by admin | Apr 25, 2023 | News & Opinions
The peptide blocks a hyperactive brain enzyme that contributes to the neurodegeneration seen in Alzheimer’s and other diseases. By Anne Trafton – MIT News MIT neuroscientists have found a way to reverse neurodegeneration and other symptoms of Alzheimer’s disease...
by admin | Apr 24, 2023 | News & Opinions
Cedars-Sinai researchers are working with Axiom Space to test if stem cells can be easily produced and grown aboard the International Space Station. By Ed Cara – Gizmodo Stem cell research is expanding beyond earthly confines. Scientists from Cedars-Sinai...
by admin | Apr 21, 2023 | News & Opinions
by Genetic Engineering and Biotechnology News If you want to know if a medical field is progressing, you can start by checking a couple of obvious indicators: the number of clinical trials, and the growth projections offered by market researchers. Both of these...
